Skip to main content

Table 3 Anti-malarial treatment practices for febrile patients 5 years and older stratified by the availability of diagnostics, use and result of malaria test

From: Changes in health workers' malaria diagnosis and treatment practices in Kenya

Patients aged ≥ 5 years

Health facilities with diagnostics

Health facilities without diagnostics

All health facilities

 

Positive

test

N = 165 (%)

Negative

test

N = 119 (%)

Test

not done

N = 245 (%)

All patients

N = 473 (%)

Total

N = 1,002 (%)

AL

143 (86.7)

39 (32.8)

142 (58.0)

327 (69.1)

651 (65.0)

SP

1 (0.6)

16 (13.5)

9 (3.7)

12 (2.5)

38 (3.8)

AL+QN

12 (7.3)

2 (1.7)

0

16 (3.4)

30 (3.0)*

QN

6 (3.6)

2 (1.7)

1 (0.4)

7 (1.5)

16 (1.6)

AQ

0

1 (0.8)

0

0

1 (0.1)

Other AM

1 (0.6)

0

1 (0.4)

2 (0.4)

4 (0.4) †

No AM prescribed

2 (1.2)

59 (49.6)

92 (37.6)

109 (23.0)

262 (26.2)

Any AM prescribed

163 (98.8)

60 (50.4)

153 (62.5)

364 (77.0)

740 (73.9)

Antibiotic prescribed

90 (54.6)

92 (82.4)

169 (69.0)

333 (70.4)

690 (68.9)

  1. *All QN treatments include administration of injectable quinine
  2. † Other anti-malarial treatment included dihydroartemisinin (2), QN+SP (1) and AL+SP (1).
  3. AL, artemether-lumefantrine; AQ, amodiaquine; SP, sulphadoxine-pyrimethamine; QN, quinine; AM, anti-malarial.